Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced the launch of My SPRYCEL Support, a useful resource to assist adult patients with chronic myeloid leukemia who are taking SPRYCEL.
Acceleron Pharma, Inc. announced preliminary results from a Phase 1b study to assess the safety, tolerability and pharmacodynamic activity of ACE-031 following multiple ascending doses in healthy postmenopausal volunteers.
Scientists have solved an important mystery about why an arsenic compound, called arsenite, can kill us, and yet function as an effective therapeutic agent against disease and infections.
Drugmaker Merck & Co. says it doesn't expect arbitrators to rule until next year on its multi-billion-dollar dispute with Johnson & Johnson over rights to two pricey drugs for immune disorders.
The lipid-transport protein apolipoprotein E4 is a major genetic risk factor for AD, and apoE4 carriers account for 65% of all Alzheimer's cases. Now, researchers from Gladstone Institutes have provided some insight into how exactly apoE4 might be involved.
States and private entities can now create prescription drug take-back programs to help people safely dispose of old or unwanted medicine.
Government health officials warned doctors and patients about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs.
The World Health Organization estimated that 1 billion of the world's poorest people suffer from neglected tropical diseases such as dengue, rabies and leprosy that remain concentrated in remote rural areas and urban slums despite being mostly eradicated elsewhere.
The Food and Drug Administration is considering new restrictions on widely used anemia drugs that appear to double the risk of stroke in patients with kidney disease.
Clinicians now are able to use, view, or assess 2D digital subtraction angiography (DSA) data without increasing X-ray dose or contrast medium. The syngo iFlow from Siemens Healthcare supports the creation of a static image displaying dynamic information, making flow visualization easier.
Alzheimer’s disease (AD) has been one of the most hotly pursued—and most elusive—therapeutic areas in biomedical research. Currently, there are no disease-modifying therapies available.
Plasticell, the biotechnology company specialising in high throughput screening for stem cell differentiation, has launched its second generation CombiCult 10,000-plex screen capable of rapidly screening up to ten thousand cell culture media combinations.
A University of Missouri researcher believes his latest work moves scientists closer to a cure for cystic fibrosis, one of the world's most common fatal genetic diseases.
Direct-to-consumer personal genetic profiling services that claim to predict people's health risks by analysing their DNA are often inconclusive and companies that sell them should provide better information about the evidence on which the results are based.